Operating cash flow remains negative at -$631.5K for 2026Q2, reflecting a persistent inability to convert accounting results into tangible liquidity.
| Cash from Operations | -3.36M | -2.82M | -1.35M | -283.16K | 363.07K | 1.02M | -71.24K |
| Operating CF Margin % | - | -9.51% | -2.62% | -0.3% | 0.42% | 1.41% | -0.12% |
| Operating CF Growth % | -1200.73% | -108.49% | -377.88% | -177.99% | -64.52% | 1536.61% | - |
| Net Income | -13.43M | -2.72M | -748.54K | 205.91K | -49.02K | -9.56K | -246.8K |
| Depreciation & Amortization | 139.31K | 19.18K | 11.65K | 2K | 1.79K | 1.16K | 454 |
| Stock-Based Compensation | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Taxes | 343 | -4 | 154 | 0 | 1.82K | -1.73K | -41 |
| Other Non-Cash Items | 11.96M | 2.13M | 128.65K | -2.41K | -10.19K | 12.14K | 320 |
| Working Capital Changes | -2.03M | -2.26M | -745.07K | -488.66K | 418.67K | 1.02M | 174.83K |
| Change in Receivables | 236.09K | 169.31K | -130.14K | -2.55K | 801.2K | 829.14K | 218.08K |
| Change in Inventory | -769.26K | -1.57M | 929.06K | 16.65M | -20.82M | 2.78M | -2.57M |
| Change in Payables | -1.57M | -509.33K | 136.43K | 807.11K | -1.66M | 1.62M | -1.47M |
| Cash from Investing | -5.97M | 3.81M | -9.47M | -2.65K | -2.93K | -1.59K | -770 |
| Capital Expenditures | -327.53K | -5.78M | -12.77K | -2.65K | -2.93K | -1.59K | -770 |
| CapEx % of Revenue | 0.51% | 19.49% | 0.02% | 0% | 0% | 0% | 0% |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - |
| Other Investing | -5.56M | 9.68M | -9.46M | 0 | 0 | 0 | 0 |
| Cash from Financing | 14.06M | 5.39M | 14.34M | 156.93K | 421.16K | -1.27M | 483.06K |
| Debt Issued (Net) | -418.88K | -307.63K | 560.8K | 144.06K | 0 | -511.67K | 483.06K |
| Equity Issued (Net) | 14.48M | 5.7M | 13.78M | 0 | 897.22K | -754.46K | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | -754.46K | 0 |
| Other Financing | 0 | 0 | 0 | 12.87K | -476.06K | 0 | 0 |
| Net Change in Cash | 4.74M | 6.35M | 3.54M | -225K | 729.74K | -159.64K | 391.49K |
| Free Cash Flow | -2.45M | -8.6M | -1.37M | -285.81K | 360.14K | 1.02M | -72.01K |
| FCF Margin % | -3.85% | -28.99% | -2.65% | -0.3% | 0.42% | 1.41% | -0.12% |
| FCF Growth % | -8.82% | -529.91% | -377.92% | -179.36% | -64.76% | 1519.04% | - |
| FCF per Share | -2.15 | -29.49 | -21.64 | -4.76 | 6.23 | 27.25 | -1.92 |
| FCF Conversion (FCF/Net Income) | 0.18x | 1.04x | 1.81x | -1.38x | -7.41x | -107.03x | 0.29x |
| Interest Paid | 0 | 0 | 0 | 1.27K | 0 | 3.47K | 9.73K |
| Taxes Paid | 0 | 0 | 0 | 598 | 26K | 9.95K | 12.67K |
Persistent negative cash burn
According to recent financial disclosures, UBXG's operating cash flow frequently diverges from net income, with the most recent period showing a net loss of $10.2 million alongside a negative operating cash flow, highlighting a fundamental inability to convert accounting results into tangible liquidity for the business.
The persistent gap between net income and operating cash flow suggests that the company's reported earnings are not supported by cash generation. Investors should monitor this disconnect, as it implies that the business model requires constant external or internal capital infusions to sustain its current operational scale.
As reported in quarterly filings, UBXG's free cash flow has remained consistently negative, with a recent outflow of $958.4K in 2026Q2, underscoring the company's struggle to achieve self-sustaining operations despite its positioning as a technology-driven infrastructure provider in the Chinese insurance market.
The negative free cash flow trajectory appears to be a structural feature rather than a temporary anomaly, given the lack of margin expansion. This trend suggests that the company may continue to deplete its cash reserves unless it can significantly pivot its cost structure or revenue recognition model.
Based on historical cash flow statements, UBXG frequently experiences significant working capital outflows, including a $258.8K drain in 2026Q2, which suggests that the company's collection cycles or inventory management are placing a persistent, heavy burden on its limited available cash resources.
The recurring negative working capital changes indicate that the company is likely struggling with delayed receivables or inefficient procurement of bundled services. This dynamic warrants further investigation, as it effectively acts as a hidden tax on the company's already razor-thin operating margins.
Financial statements indicate that UBXG's capital expenditure, reaching 2.8% of revenue in 2026Q2, is disproportionately high relative to its shrinking top-line, suggesting that the company is forced to reinvest in infrastructure just to maintain its current, low-margin service delivery capabilities.
The capital intensity appears to be a defensive necessity rather than a growth-oriented investment, given the lack of corresponding revenue expansion. This suggests that the company may be trapped in a cycle of maintenance spending that fails to generate a meaningful return on invested capital.
Quick answers to the most common questions about buying UBXG stock.
U-BX Technology Ltd. (UBXG) generated $-2.8M in net cash from operating activities in 2025. This reflects the cash generated directly from core business operations.
U-BX Technology Ltd. (UBXG) reported negative free cash flow of $8.6M in 2025, indicating capital requirements exceeded cash from operations.
U-BX Technology Ltd. (UBXG) spent $5.8M on capital expenditures in 2025. CapEx represents the cash invested in physical assets like property, plant, and equipment to maintain or grow the business.